Politan Capital Investment in Masimo
Hedge Fund Presentation Collection
In 2023, Politan Capital Management acquired an 8.4% stake in Masimo Corporation, advocating for improved corporate governance and nominating two candidates to the board to address undervaluation, broken governance, and enhance capital allocation and strategy.
| Fund | Politan Capital |
| Target | Masimo |
| Sector | Healthcare |
| Year | 2023 |
Politan Capital invested in Masimo in 2023 and made public a presentation for it. If you are interested to learn about how hedge funds write presentations, here is one for you to learn from.
The Politan Capital Deck
This deck is in the public domain (Nothing privately shared is ever distributed on this site).
About the Masimo deal
In 2023, Politan Capital Management, an activist investor, acquired an 8.4% stake in Masimo Corporation, a medical device maker. Politan believed that Masimo’s shares were undervalued and represented an attractive investment opportunity. Politan has been advocating for change in Masimo’s corporate governance, emphasizing the need for independent oversight and greater accountability on the company’s board. They have nominated two qualified candidates, Michelle Brennan and Quentin Koffey, for election to Masimo’s Board at the Annual Meeting of Stockholders, which is scheduled for June 26, 2023. Politan’s investment in Masimo amounts to approximately $800 million. The investor aims to address the company’s broken governance, enhance capital allocation, and refocus its strategy to unlock its full potential.
About Politan Capital
Politan Capital Management is an activist hedge fund founded by Quentin Koffey in 2021. The firm focuses on investing in publicly traded companies and seeks to influence their management and strategic direction to enhance shareholder value. Politan Capital employs a hands-on approach, engaging with company boards and management teams to drive operational improvements, strategic changes, and governance enhancements. Despite being relatively new, the firm has quickly gained attention in the financial industry for its assertive and impactful activism.
About Masimo
Masimo Corporation is a global medical technology company founded in 1989 by Joe Kiani. Headquartered in Irvine, California, Masimo is known for its innovative non-invasive monitoring technologies, particularly pulse oximetry, which measures oxygen levels in the blood. The company’s flagship product, the Masimo SET® pulse oximeter, is widely used in hospitals and other healthcare settings due to its accuracy and reliability. Masimo’s product portfolio also includes a range of patient monitoring devices, wearable health solutions, and automation systems designed to improve patient outcomes and safety. The company is committed to advancing healthcare through continuous innovation and research.
Want to see more?
Head here to see the rest of the collection:
Comments (0)
There are no comments yet :(